Federated Hermes
ACET icon

Federated Hermes’s Adicet Bio ACET Stock Holding History

Federated Hermes’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-72
Closed -$1.4K – 2056
2024
Q2 		$1.4K Buy
+72
New +$1.93K ﹤0.01% 1928
2024
Q1 		– Sell
-214
Closed -$6.47K – 2023
2023
Q4 		$6.47K Buy
214
+68
+47% +$1.48K ﹤0.01% 1830
2023
Q3 		$3.21K Buy
146
+128
+711% +$4.52K ﹤0.01% 1926
2023
Q2 		$690 Buy
+18
New +$1.59K ﹤0.01% 2041
2021
Q1 		– Sell
-4
Closed -$1K – 2208
2020
Q4 		$1K Sell
4
-12
-75% -$2.46K ﹤0.01% 2151
2020
Q3 		$3K Sell
16
-7
-30% -$1.77K ﹤0.01% 2064
2020
Q2 		$6K Buy
23
+12
+109% +$2.36K ﹤0.01% 1977
2020
Q1 		$1K Buy
+11
New +$1.63K ﹤0.01% 2064

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Federated Hermes's ACET Position: Q3 2024 in Review

Federated Hermes sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 72 shares — an estimated $1.4K sold.

Federated Hermes first reported a position in ACET in Q1 2020 and held it in 8 quarters. The position peaked at $6.47K in Q4 2023. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • Federated Hermes reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • Federated Hermes sold 72 Adicet Bio shares in Q3 2024, an estimated $1.4K.
  • Federated Hermes first reported a position in Adicet Bio in Q1 2020 and held it in 8 quarters.
  • Federated Hermes's Adicet Bio position peaked at $6.47K in Q4 2023.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on Federated Hermes's 13F filing for Q3 2024, filed 13 Nov 2024.